What does ST depression in leads V5 and V6 indicate and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

ST Depression in V5 and V6: Interpretation and Management

ST depression in leads V5 and V6 most commonly indicates lateral wall ischemia or serves as a reciprocal change from an acute inferior or posterior myocardial infarction, requiring urgent risk stratification and consideration for immediate invasive management.

Clinical Significance

ST depression in the lateral precordial leads (V5-V6) carries distinct prognostic implications depending on the clinical context:

In Acute Inferior MI

When ST depression appears in V5-V6 during acute inferior STEMI, this represents a high-risk feature indicating:

  • Multivessel disease: Widespread ST depression extending to V5-V6 (beyond V1-V4) strongly predicts significant left anterior descending (LAD) artery disease with 92% sensitivity and 86% positive predictive value 1. This pattern suggests more extensive coronary involvement than isolated inferior ST depression in V1-V4.

  • Worse outcomes: Patients with left precordial ST depression (V4-V6) during inferior MI demonstrate higher in-hospital mortality, more advanced coronary disease, and greater left ventricular dysfunction compared to those without these changes 2. The 2025 study confirms that ST depression in V4-V6 correlates with multivessel stenosis and poorer cardiac outcomes 3.

As Primary Ischemic Change

ST depression isolated to V5-V6 without ST elevation elsewhere may indicate:

  • Lateral wall ischemia: Direct ischemia affecting the lateral left ventricular wall supplied by the left circumflex artery
  • Posterior MI equivalent: ST depression in lateral leads can represent reciprocal changes from true posterior wall infarction (though this more classically appears in V1-V3) 4

Management Algorithm

Immediate Assessment (Within Minutes)

  1. Obtain full 12-lead ECG to identify:

    • Presence of ST elevation in inferior leads (II, III, aVF) suggesting acute inferior MI with reciprocal lateral changes
    • ST elevation in posterior leads (V7-V9) if posterior MI suspected
    • Extent of ST depression (localized V5-V6 vs. widespread V1-V6)

  2. Check for very high-risk features requiring immediate invasive strategy (<2 hours) 5:

    • Hemodynamic instability or cardiogenic shock
    • Recurrent chest pain despite medical treatment
    • Life-threatening arrhythmias
    • ST depression >1 mm in ≥6 leads plus ST elevation in aVR/V1

Risk Stratification

If ST depression in V5-V6 occurs with inferior STEMI:

  • This mandates immediate invasive strategy as it indicates high-risk anatomy with likely multivessel disease 1
  • Proceed directly to cardiac catheterization without delay

If isolated ST depression in V5-V6 (NSTE-ACS):

  • Calculate GRACE risk score
  • Early invasive strategy within 24 hours is indicated for 5:
    • NSTEMI diagnosis confirmed by troponin elevation
    • Dynamic ST/T changes suggesting ongoing ischemia
    • GRACE score >140

Acute Medical Management

While arranging invasive strategy:

  • Dual antiplatelet therapy: Aspirin plus P2Y12 inhibitor (clopidogrel preferred if on oral anticoagulation) 5
  • Anticoagulation: Parenteral anticoagulant during PCI
  • Beta-blockers: For ongoing ischemic symptoms if no contraindications 5
  • IV nitrates: If hypertensive or signs of heart failure 5

Invasive Strategy

  • Radial access is the standard approach 5
  • Drug-eluting stents are recommended over bare-metal stents 5
  • Revascularization strategy (culprit-only vs. multivessel PCI vs. CABG) should be based on disease severity and SYNTAX score 5

Critical Pitfalls to Avoid

  1. Do not dismiss widespread ST depression (V1-V6) as "non-specific": This pattern in inferior MI specifically predicts LAD disease requiring comprehensive revascularization 1

  2. Do not delay catheterization: ST depression in V5-V6 with inferior MI represents a high-risk subset requiring immediate intervention, not conservative management 2

  3. Consider left main disease: ST depression in V5 combined with large reciprocal ST depression in inferior leads may indicate left main trunk occlusion, which carries extremely high mortality 6

  4. Evaluate for posterior MI: Always obtain posterior leads (V7-V9) when lateral ST depression is present to rule out true posterior STEMI requiring immediate reperfusion 4

The key principle is that ST depression in V5-V6 is never benign in the acute setting and demands urgent evaluation for active coronary ischemia with appropriate invasive management based on risk stratification.

References

Related Questions

What is the significance and recommended management of ST‑segment depression in ECG leads V1 to V3?
What first‑line antidepressant medication and dosing is recommended for a 14‑year‑old Asian boy with depression, including monitoring guidelines and alternative options?
What medication treatment is recommended for a 17-year-old with major depressive disorder and adjustment disorder?
In a 40‑year‑old patient with long‑standing arterial hypertension, elevated LDL cholesterol, left‑ventricular hypertrophy and mild repolarisation abnormalities on ECG, and an exercise stress test showing 1 mm ST‑segment depression at rest and 3 mm depression during exertion, what is the next appropriate diagnostic step: cardiac echocardiography, 24‑hour Holter monitoring, coronary angiography, or thallium stress‑perfusion imaging?
What is the appropriate treatment for a 14-year-old patient with Major Depressive Disorder (MDD) and auditory hallucinations?
Should statin therapy be recommended for all patients with carotid artery plaque regardless of traditional cardiovascular risk factors?
What is the incidence of postoperative acute kidney injury after non‑cardiac surgery?
Will jaundice and elevated bilirubin resolve in hereditary spherocytosis?
When should a thrombophilia screen be performed in a young man with recurrent deep vein thrombosis who is taking apixaban?
What are the indications, dosing regimen, monitoring requirements, and contraindications for using deferiprone in patients aged three years or older with transfusional iron overload such as thalassemia or sickle‑cell disease?
When should platelet transfusion be given to a postpartum woman with immune thrombocytopenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.